Inhibition of Pulmonary Eosinophilia and Hyperreactivity by Antibodies to lnterleukin-5
Robert W. Egan(AIL Research (United States)), Mark Bodmer(UCB Pharma (United Kingdom)), Diljeet Athwahl(AGCO (United Kingdom)), Nicholas Murgolo(Merck & Co., Inc., Rahway, NJ, USA (United States)), Ted T. Kung(AGCO (United Kingdom)), Peter Mauser(AGCO (United Kingdom)), Chuan‐Chu Chou(AGCO (United Kingdom)), Spencer Emtage(UCB Pharma (United Kingdom)), Chung-Her Jehn(AGCO (United Kingdom))
Cited by 68
Related Papers
Critical Assessment of Metagenome Interpretation—a benchmark of metagenomics software
|Nature Methods|2017|970
Antibiotic Susceptibility Profiles of <i>Escherichia coli</i> Strains Lacking Multidrug Efflux Pump Genes
|Antimicrobial Agents and Chemotherapy|2001|502
Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis
|Critical Care Medicine|1993|431